Rocamora-Blanch Gemma, Climent Fina, Solanich Xavier
Servicio de Medicina Interna, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Barcelona, España; Instituto de Investigación Biomédica de Bellvitge (IDIBELL), L'Hospitalet de Llobregat, Barcelona, España.
Instituto de Investigación Biomédica de Bellvitge (IDIBELL), L'Hospitalet de Llobregat, Barcelona, España; Servicio de Anatomía Patológica, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Barcelona, España.
Med Clin (Barc). 2023 Aug 25;161(4):166-175. doi: 10.1016/j.medcli.2023.05.001. Epub 2023 May 30.
Histiocytosis is a group of rare diseases characterized by inflammation and accumulation of cells derived from monocytes and macrophages in different tissues. The symptoms are highly variable, from mild forms with involvement of a single organ to severe multisystem forms that can be life compromising. The diagnosis of histiocytosis is based on the clinic, radiological findings and pathological anatomy. A biopsy of the affected tissue is recommended in all cases as it may have therapeutic implications. During the last decade, some mutations have been identified in the affected tissue that condition activation of the MAPK/ERK and PI3K/AKT pathway, in a variable proportion depending on the type of histiocytosis. In this review we mainly focus on Langerhans Cell Histiocytosis, Erdheim-Chester Disease and Rosai-Dorfman Disease.
组织细胞增多症是一组罕见疾病,其特征是不同组织中源自单核细胞和巨噬细胞的细胞发生炎症和积聚。症状差异很大,从累及单个器官的轻度形式到可能危及生命的严重多系统形式。组织细胞增多症的诊断基于临床、影像学表现和病理解剖。所有病例均建议对受累组织进行活检,因为这可能具有治疗意义。在过去十年中,已在受累组织中鉴定出一些突变,这些突变会导致MAPK/ERK和PI3K/AKT通路的激活,激活比例因组织细胞增多症的类型而异。在本综述中,我们主要关注朗格汉斯细胞组织细胞增多症、厄尔德海姆-切斯特病和罗萨伊-多夫曼病。